Exoxemis Exoxemis - Company
Home Technology Indications Collaborations Company Publications Contact
Vision and Values Intellectual Property
 
>

Vision and Values

The Exoxemis technology platform has the potential to change the paradigm of infectious disease prevention and treatment by providing an alternative to existing antibiotics and other anti-infectives.
more >>

 
       
>

Intellectual Property

We offer a comprehensive intellectual property portfolio in MPO and EPO technologies protected by more than 20 patents worldwide.

   
       
>

E-mail Inquiries

   

Intellectual Property

Exoxemis offers a comprehensive intellectual property portfolio in myeloperoxidase (MPO) and eosinophil peroxidase (EPO) technologies. Protected by more than 20 patents worldwide, this portfolio covers research and development, manufacturing, formulation, and delivery.

Haloperoxidase Acid Optimum Chemiluminescence Assay System
Patent Title Country Patent Number
Haloperoxidase Acid Optimum Chemiluminescence Assay System U.S.A 5,556,758
EPC 0421788
Israel 95900
Germany 690 28 591
Canada*
2,026,809
Japan 3184894
Ireland 82106
* Issued December 2003

Oxygen Activatable Formulations for Disinfection or Sterilization
Patent Title Country Patent Number
Oxygen Activatable Formulations for Disinfection or Sterilization U.S.A 5,756,090
U.S.A 6,033,662
U.S.A* 6,503,507
Australia 708557
EPC** 0832198
* Issued January 2003
** Issued July 2003

Treatment of Infection and the Control of Flora Using Haloperoxidase
Patent Title Country Patent Number
Methods and Compositions for the Treatment of Infection and the Control of Flora Using Haloperoxidase Australia 663869
EPC 0500387
Canada*
2,061,601
Ireland** 083079
* Issued April 2003
** Issued September 2003

Killing or Inhibition of Yeast and Sporular Microorganisms
Patent Title Country Patent Number
Fungicidal methods and compositions for killing yeast and sporular microorganisms Australia 679777
EPC
0713527
Korea 325,901
China 83564
Method for killing or inhibiting the growth of sporulating microorganisms with haloperoxidase containing compositions U.S.A. 5,510,104
U.S.A. 5,451,402
Haloperoxidase containing compositions for killing yeast and sporular microorganisms U.S.A 5,389,369

The Prevention and Treatment of STDs
Patent Title Country Patent Number
Method which utilizes a haloperoxidase composition to inhibit the growth of microorganisms which cause sexually transmitted diseases U.S.A 5,565,197
Methods and compositions for the prevention or treatment of sexually transmitted diseases Australia 684505
Korea 306,968
EPC 0693934
Methods for inhibiting the transmission of sexually transmitted diseases U.S.A 5,718,896

Chemiluminescence Assay of In Vivo Inflammation
Patent Title Country Patent Number
Chemiluminescence Assay of In Vivo Inflammation U.S.A 5,108,899
EPC 0430440

Other methods and compositions patents
Patent Title Country Patent Number
Method for selectively inhibiting the growth of microbes using a haloperoxidase-halide-peroxide system U.S.A 5,888,505
Method for Inhibiting Pathogenic Microbes in an Animal Using a Haloperoxidase-Halide-Peroxide System U.S.A* 6,294,168
Microporous pathogen-killing composition Australia 703034
Compositions comprising haloperoxidase for inhibiting the growth of pathogenic microbes and a method for inhibiting growth of pathogenic microbes using said compositions Israel 100997
* Seminal patent issued September 2001